Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lulu Cheng

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Scientific Reports|May 3, 2024
Ideal cardiovascular health index and high-normal blood pressure in elderly people: evidence based on real-world dataYongcheng Ren, Lulu Cheng, Yaoyu Song, et al.
BMJ Oncology|January 31, 2025
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumoursAung Naing, Kyriakos P Papadopoulos, Michael J Pishvaian, et al.
Nature Communications|July 28, 2025
Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastomaLulu Cheng, Zezheng Fang, Junpeng Wang, et al.
Genome Biology|August 7, 2023
3D organization of regulatory elements for transcriptional regulation in ArabidopsisLi Deng, Qiangwei Zhou, Jie Zhou, et al.
Frontiers in Molecular Neuroscience|January 31, 2018
Recapitulating X-Linked Juvenile Retinoschisis in Mouse Model by Knock-In Patient-Specific Novel MutationDing Chen, Tao Xu, Mengjun Tu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 8, 2023
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic MalignanciesManish R Patel, William Donnellan, Michael Byrne, et al.
Frontiers in Neuroscience|August 18, 2022
Increased functional connectivity of white-matter in myotonic dystrophy type 1Jing Li, Jie Li, Pei Huang, et al.
Clinical and Molecular Hepatology|October 14, 2025
Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-HT productionDianji Tu, Cheng Lu, Junfeng Guo, et al.
Cancer Research|July 14, 2026
ALKBH5 in Cancer-Associated Fibroblasts Governs an Epitranscriptomic Axis that Drives Pancreatic Cancer MetastasisXianglin Yin, Xiao-Ding Liu, Lulu Cheng, et al.
Lancet (London, England)|May 30, 2026
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trialGeorg Lenz, Marek Trněný, John M Burke, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Scientific Reports|May 3, 2024
Ideal cardiovascular health index and high-normal blood pressure in elderly people: evidence based on real-world dataYongcheng Ren, Lulu Cheng, Yaoyu Song, et al.
BMJ Oncology|January 31, 2025
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumoursAung Naing, Kyriakos P Papadopoulos, Michael J Pishvaian, et al.
Nature Communications|July 28, 2025
Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastomaLulu Cheng, Zezheng Fang, Junpeng Wang, et al.
Genome Biology|August 7, 2023
3D organization of regulatory elements for transcriptional regulation in ArabidopsisLi Deng, Qiangwei Zhou, Jie Zhou, et al.
Frontiers in Molecular Neuroscience|January 31, 2018
Recapitulating X-Linked Juvenile Retinoschisis in Mouse Model by Knock-In Patient-Specific Novel MutationDing Chen, Tao Xu, Mengjun Tu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 8, 2023
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic MalignanciesManish R Patel, William Donnellan, Michael Byrne, et al.
Frontiers in Neuroscience|August 18, 2022
Increased functional connectivity of white-matter in myotonic dystrophy type 1Jing Li, Jie Li, Pei Huang, et al.
Clinical and Molecular Hepatology|October 14, 2025
Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-HT productionDianji Tu, Cheng Lu, Junfeng Guo, et al.
Cancer Research|July 14, 2026
ALKBH5 in Cancer-Associated Fibroblasts Governs an Epitranscriptomic Axis that Drives Pancreatic Cancer MetastasisXianglin Yin, Xiao-Ding Liu, Lulu Cheng, et al.
Lancet (London, England)|May 30, 2026
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trialGeorg Lenz, Marek Trněný, John M Burke, et al.
Pageof 8